ALKS vs DHR · P/E 14, rev $1.56B vs P/E 39, rev $24.57B
Alkermes Plc (ALKS) versus Danaher Corporation (DHR) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
Danaher Corporation (DHR) is a diagnostics & research company listed on US.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported DHR revenue for 2025-12-31 was $24.57B. Net income was $3.61B. Revenue was up 2.9% from 2024-12-31 to 2025-12-31. DHR currently screens at market cap $144.18B and trailing P/E 39.0.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. DHR currently screens at market cap $144.18B and trailing P/E 39.0.
Not investment advice. Open the ALKS and DHR stock pages for the full models.
Not investment advice.